SwePub
Sök i LIBRIS databas

  Utökad sökning

(WFRF:(Wojdyla Daniel M.))
 

Sökning: (WFRF:(Wojdyla Daniel M.)) > (2015-2019) > Characteristics and...

Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)

Goldstein, Sarah A. (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
Green, Jennifer (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
Huber, Kurt (författare)
Med Univ Vienna, Med Dept 3, Cardiol, Wilhelminenspital, Vienna, Austria
visa fler...
Wojdyla, Daniel M. (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
Lopes, Renato D. (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
Alexander, John H. (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
Vinereanu, Dragos (författare)
Univ Med & Pharm Carol Davila, Univ & Emergency Hosp, Bucharest, Romania
Wallentin, Lars, 1943- (författare)
Uppsala universitet,Uppsala kliniska forskningscentrum (UCR)
Granger, Christopher B. (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
Al-Khatib, Sana M. (författare)
Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
visa färre...
 (creator_code:org_t)
Elsevier BV, 2019
2019
Engelska.
Ingår i: American Journal of Cardiology. - : Elsevier BV. - 0002-9149 .- 1879-1913. ; 124:9, s. 1406-1412
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Whether patients with atrial fibrillation (AF) and thyroid disease are clinically distinct from those with AF and no thyroid disease is unknown. Furthermore, the effectiveness of anticoagulation for prevention of AF-related thromboembolic events in patients with thyroid disease has not been adequately studied. Patients enrolled in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation, which compared apixaban with warfarin in patients with AF (n = 18,201), were categorized by thyroid disease history at randomization (hypothyroidism, hyperthyroidism, and no thyroid disease). Adjusted hazard ratios derived from Cox models were used to compare outcomes by thyroid disease history. Associations between randomized treatment and outcomes by thyroid disease history were examined using Cox models with interaction terms. A total of 18,021/18,201 (99%) patients had available thyroid disease history at randomization: 1,656 (9%) had hypothyroidism, 321 (2%) had hyperthyroidism, and 16,044 (89%) had no thyroid disease. When compared with those without a history of thyroid disease, patients with hypo- or hyperthyroidism were more likely to be female (60.4% vs 32.1%; 52.0% vs 32.1%; both p < 0.0001). Patients with hypothyroidism were older (73 vs 70 years, p < 0.0001) and more likely to have had previous falls (8.7% vs 4.3%, p < 0.0001). There was no difference in clinical outcomes by thyroid disease history. The benefit of apixaban compared with warfarin was similar regardless of thyroid disease history (interaction p > 0.10). In conclusion, despite differences in baseline characteristics of patients with and without thyroid disease, their clinical outcomes were similar. The benefit of apixban compared with warfarin was preserved regardless of thyroid disease history.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy